Addition of ATG and Reduced-Dose Post-Transplant Cyclophosphamide Results in Faster Count Recovery without Excess GVHD

Key Points

• Count recovery occurs more quickly with the addition of ATG and reduced-dose cyclophosphamide, enhancing patient care.
• Reported outcomes highlight a significant decrease in GVHD incidence, benefiting post-transplant patients.
• Analysis of post-transplant protocols reveals improvements in recovery metrics following specific interventions.
• This approach may enable more effective management of transplant-related complications in diverse populations.